2018
DOI: 10.21873/anticanres.12267
|View full text |Cite
|
Sign up to set email alerts
|

Phosphaplatin Anti-tumor Effect Enhanced by Liposomes Partly via an Up-regulation of PEDF in Breast Cancer

Abstract: Free RRD4 or formulated into liposomes, are excellent candidates for adjuvant therapy against breast tumor growth and metastasis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 43 publications
0
0
0
Order By: Relevance
“…Many publications highlight that the biological functions of PEDF are diverse and multidimensional [58,64,65]. Some assays link the PEDF molecule to mechanisms that suppress breast cancer metastasis by regulating the epithelial-mesenchymal transition [66][67][68][69]; others report surprising observations, such as that PEDF constitutively activates p42/44 MAPK/Erk but paradoxically does not affect mitogenic signaling [70]. The angiogenic potential of PEDF as an antineoplastic therapy is particularly noteworthy [18,[71][72][73][74].…”
Section: Introductionmentioning
confidence: 99%
“…Many publications highlight that the biological functions of PEDF are diverse and multidimensional [58,64,65]. Some assays link the PEDF molecule to mechanisms that suppress breast cancer metastasis by regulating the epithelial-mesenchymal transition [66][67][68][69]; others report surprising observations, such as that PEDF constitutively activates p42/44 MAPK/Erk but paradoxically does not affect mitogenic signaling [70]. The angiogenic potential of PEDF as an antineoplastic therapy is particularly noteworthy [18,[71][72][73][74].…”
Section: Introductionmentioning
confidence: 99%